Advanced Biomed Inc. entered a definitive agreement to acquire 100% of Acellent Technologies (Hong Kong) Co. Limited for $1.08 million in stock, contingent on due diligence and regulatory approvals.
Key takeaways
Company agreed to acquire 100% equity interest in Acellent Technologies, a provider of AI-powered financial verification and audit solutions.
Total consideration is 270,000 shares of common stock, valued at $4.00 per share for an aggregate estimated value of $1,080,000.
Transaction closing is subject to completion of financial and legal due diligence and receipt of required regulatory approvals.
The Share Purchase Agreement is dated April 2, 2026, with the seller identified as Xiaomin Chen.